Acute disseminated encephalomyelitis following influenza vaccination

Vaccine

Volumn 29, Issue 46, 2011, Pages 8182-8185

  Shoamanesh, A ^a   Traboulsee, A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Encephalomyelitis; Influenza; Post influenza; Vaccination; Vaccine

Indexed keywords

ACICLOVIR; C REACTIVE PROTEIN; GADOLINIUM; INFLUENZA VACCINE; METHYLPREDNISOLONE;

ABDUCENS NERVE PARALYSIS; ACUTE DISSEMINATED ENCEPHALOMYELITIS; AGED; ARTHROPATHY; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; DEATH; DISEASE ASSOCIATION; DRUG SAFETY; DYSARTHRIA; DYSLIPIDEMIA; FATIGUE; FEMALE; HEADACHE; HEMIPARESIS; HEMIPLEGIA; HICCUP; HUMAN; HUMAN CELL; HYPERTENSION; HYPOTHYROIDISM; INCONTINENCE; INFLUENZA VACCINATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALAISE; MEDULLA OBLONGATA; MONOCYTE; NAUSEA AND VOMITING; NEUTROPHIL COUNT; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; PLEOCYTOSIS; PNEUMONIA; PRIORITY JOURNAL; QUADRIPLEGIA; SEASONAL INFLUENZA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; CHILD, PRESCHOOL; ENCEPHALOMYELITIS, ACUTE DISSEMINATED; FATAL OUTCOME; FEMALE; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; PLASMA EXCHANGE; PREDNISOLONE; VACCINATION;

EID: 80053978406     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.08.103     Document Type: Article

References (20)

1. Leake J.A., Albani S., Kao A.S., Senac M.O., Billman G.F., Nespeca M.P., et al. Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J 2004, 23:756-764.
2. Fenichel G.M. Neurological complications of immunization. Ann Neurol 1982, 12:119-128.
3. Takahashi H., Pool V., Tsai T.F., Chen R.T. Adverse events after Japanese encephalitis vaccination: review of post-marketing surveillance data from Japan and the United States. The VAERS Working Group. Vaccine 2000, 18:2963-2969.
4. Ohtaki E., Matsuishi T., Hirano Y., Maekawa K. Acute disseminated encephalomyelitis after treatment with Japanese B encephalitis vaccine (Nakayama-Yoken and Beijing strains). J Neurol Neurosurg Psychiatry 1995, 59:316-317.
5. Hemachudha T., Griffin D.E., Giffels J.J., Johnson R.T., Moser A.B., Phanuphak P. Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. N Engl J Med 1987, 316:369-374.
6. Ubol S., Hemachudha T., Whitaker J.N., Griffin D.E. Antibody to peptides of human myelin basic protein in post-rabies vaccine encephalomyelitis sera. J Neuroimmunol 1990, 26:107-111.
7. Sejvar J.J., Kohl K.S., Bilynsky R., Blumberg D., Cvetkovich T., Galama J., et al. Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2007, 25:5771-5792.
8. Huynh W., Cordato D.J., Kehdi E., Masters L.T., Dedousis C. Post-vaccination encephalomyelitis: literature review and illustrative case. J Clin Neurosci 2008, 15:1315-1322.
9. Antony S.J., Fleming D.F., Bradley T.K. Postvaccinial (influenza) disseminated encephalopathy (Brown-Sequard syndrome). J Natl Med Assoc 1995, 87:705-708.
10. Vilain S., Waterschoot M.P., Mavroudakis N. Encephalomyelitis and bilateral optic perineuritis after influenza vaccination. Bull Soc Belg Ophtalmol 2000, 71-73.
11. Nakamura N., Nokura K., Zettsu T., Koga H., Tachi M., Terada M., et al. Neurologic complications associated with influenza vaccination: two adult cases. Intern Med 2003, 42:191-194.
12. Ravaglia S., Ceroni M., Moglia A., Todeschini A., Marchioni E. Post-infectious and post-vaccinal acute disseminated encephalomyelitis occurring in the same patients. J Neurol 2004, 251:1147-1150.
13. Izurieta H.S., Haber P., Wise R.P., Iskander J., Pratt D., Mink C., et al. Adverse events reported following live, cold-adapted, intranasal influenza vaccine. JAMA 2005, 294:2720-2725.
14. Nakayama T., Onoda K. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004. Vaccine 2007, 25:570-576.
15. Vellozzi C., Burwen D.R., Dobardzic A., Ball R., Walton K., Haber P. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine 2009, 27:2114-2120.
16. Turkoglu R., Tuzun E. Brainstem encephalitis following influenza vaccination: favorable response to steroid treatment. Vaccine 2009, 27:7253-7256.
17. Kavadas F.D., Bitnun A., MacGregor D., Heurter H., Ford Jones E.L. Acute neurological events associated with influenza vaccination: are the WHO criteria for assessing causality adequate?. Scand J Infect Dis 2008, 40:565-570.
18. Lapphra K., Huh L., Scheifele D.W. Adverse neurologic reactions after both doses of pandemic H1n1 influenza vaccine with optic neuritis and demyelination. Pediatr Infect Dis J 2010.
19. Markovic-Plese S., Hemmer B., Zhao Y., Simon R., Pinilla C., Martin R. High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: implications for the initiation of autoimmune response in multiple sclerosis. J Neuroimmunol 2005, 169:31-38.
20. Collet J.P., MacDonald N., Cashman N., Pless R. Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee. Advisory Committee on Causality Assessment. Bull World Health Organ 2000, 78:178-185.